Titre : Synaptogyrines

Synaptogyrines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cardiovascular System
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Synaptogyrines : Questions médicales les plus fréquentes", "headline": "Synaptogyrines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Synaptogyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Synaptogyrines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de tissu nerveux", "url": "https://questionsmedicales.fr/mesh/D009419", "about": { "@type": "MedicalCondition", "name": "Protéines de tissu nerveux", "code": { "@type": "MedicalCode", "code": "D009419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.631" } } }, "about": { "@type": "MedicalCondition", "name": "Synaptogyrines", "alternateName": "Synaptogyrins", "code": { "@type": "MedicalCode", "code": "D062805", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lingfei Li", "url": "https://questionsmedicales.fr/author/Lingfei%20Li", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Philip Wing-Lok Ho", "url": "https://questionsmedicales.fr/author/Philip%20Wing-Lok%20Ho", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Shirley Yin-Yu Pang", "url": "https://questionsmedicales.fr/author/Shirley%20Yin-Yu%20Pang", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Zoe Yuen-Kiu Choi", "url": "https://questionsmedicales.fr/author/Zoe%20Yuen-Kiu%20Choi", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China." } }, { "@type": "Person", "name": "Yasine Malki", "url": "https://questionsmedicales.fr/author/Yasine%20Malki", "affiliation": { "@type": "Organization", "name": "Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The potential therapeutic impacts of trehalose on cardiovascular diseases as the environmental-influenced disorders: An overview of contemporary findings.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36925035", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envres.2023.115674" } }, { "@type": "ScholarlyArticle", "name": "Consumption of very low-mineral water may threaten cardiovascular health by increasing homocysteine in children.", "datePublished": "2023-03-09", "url": "https://questionsmedicales.fr/article/36969809", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fnut.2023.1133488" } }, { "@type": "ScholarlyArticle", "name": "Heart Rate Recovery Assessed by Cardiopulmonary Exercise Testing in Patients with Cardiovascular Disease: Relationship with Prognosis.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36981587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20064678" } }, { "@type": "ScholarlyArticle", "name": "Cardiovascular Risk Factors in Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.", "datePublished": "2023-03-05", "url": "https://questionsmedicales.fr/article/36871179", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ohn.163" } }, { "@type": "ScholarlyArticle", "name": "Cardiovascular Disease-Related Emergency Department Visits and Hospitalization among Women with Hypertensive Disorders of Pregnancy.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36863895", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.amepre.2023.01.004" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de tissu nerveux", "item": "https://questionsmedicales.fr/mesh/D009419" }, { "@type": "ListItem", "position": 5, "name": "Synaptogyrines", "item": "https://questionsmedicales.fr/mesh/D062805" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Synaptogyrines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Synaptogyrines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Synaptogyrines", "description": "Comment diagnostiquer une anomalie des synaptogyrines ?\nQuels examens sont utilisés pour évaluer les synaptogyrines ?\nLes tests génétiques sont-ils fiables pour les synaptogyrines ?\nQuels symptômes peuvent indiquer un problème avec les synaptogyrines ?\nPeut-on détecter les synaptogyrines par des analyses sanguines ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Synaptogyrines", "description": "Quels sont les symptômes associés aux dysfonctionnements des synaptogyrines ?\nLes troubles moteurs sont-ils liés aux synaptogyrines ?\nLes troubles cognitifs peuvent-ils être causés par des anomalies des synaptogyrines ?\nLes convulsions sont-elles fréquentes avec des problèmes de synaptogyrines ?\nPeut-on observer des changements de comportement liés aux synaptogyrines ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Synaptogyrines", "description": "Peut-on prévenir les troubles liés aux synaptogyrines ?\nLe dépistage précoce est-il important pour les synaptogyrines ?\nLes conseils génétiques sont-ils recommandés pour les familles ?\nY a-t-il des facteurs environnementaux à surveiller ?\nLes vaccinations peuvent-elles prévenir des troubles neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Synaptogyrines", "description": "Quels traitements sont disponibles pour les troubles liés aux synaptogyrines ?\nLa thérapie génique est-elle une option pour les anomalies des synaptogyrines ?\nLes médicaments peuvent-ils améliorer les symptômes liés aux synaptogyrines ?\nDes interventions chirurgicales sont-elles possibles pour ces troubles ?\nLes thérapies physiques sont-elles bénéfiques pour les patients ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Synaptogyrines", "description": "Quelles complications peuvent survenir avec des troubles des synaptogyrines ?\nLes troubles de l'humeur sont-ils des complications possibles ?\nLes patients peuvent-ils développer des troubles psychiatriques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il un risque accru de mortalité avec ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Synaptogyrines", "description": "Quels sont les facteurs de risque pour les troubles des synaptogyrines ?\nL'hérédité joue-t-elle un rôle dans les troubles des synaptogyrines ?\nLes infections prénatales peuvent-elles affecter les synaptogyrines ?\nLe stress environnemental est-il un facteur de risque ?\nLes facteurs nutritionnels influencent-ils les troubles des synaptogyrines ?", "url": "https://questionsmedicales.fr/mesh/D062805?mesh_terms=Cardiovascular+System&page=997#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie des synaptogyrines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des analyses de protéines neuronales." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les synaptogyrines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie cérébrale et des biopsies peuvent être réalisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables pour les synaptogyrines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier des mutations spécifiques des synaptogyrines." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les synaptogyrines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques, des convulsions ou des retards de développement peuvent survenir." } }, { "@type": "Question", "name": "Peut-on détecter les synaptogyrines par des analyses sanguines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les synaptogyrines sont principalement étudiées dans le tissu cérébral." } }, { "@type": "Question", "name": "Quels sont les symptômes associés aux dysfonctionnements des synaptogyrines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de l'humeur, des problèmes de mémoire et des convulsions." } }, { "@type": "Question", "name": "Les troubles moteurs sont-ils liés aux synaptogyrines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles moteurs peuvent survenir en raison de dysfonctionnements synaptiques." } }, { "@type": "Question", "name": "Les troubles cognitifs peuvent-ils être causés par des anomalies des synaptogyrines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et des retards de développement." } }, { "@type": "Question", "name": "Les convulsions sont-elles fréquentes avec des problèmes de synaptogyrines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les convulsions sont un symptôme courant des dysfonctionnements des synaptogyrines." } }, { "@type": "Question", "name": "Peut-on observer des changements de comportement liés aux synaptogyrines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements de comportement peuvent être observés en cas de dysfonctionnement." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux synaptogyrines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de méthodes de prévention spécifiques pour ces troubles." } }, { "@type": "Question", "name": "Le dépistage précoce est-il important pour les synaptogyrines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un dépistage précoce peut aider à gérer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils recommandés pour les familles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques de transmission." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à surveiller ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs environnementaux peuvent influencer la santé neurologique, mais peu sont connus." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir des troubles neurologiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui affectent le système nerveux." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles liés aux synaptogyrines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anticonvulsivants et des thérapies comportementales." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour les anomalies des synaptogyrines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils améliorer les symptômes liés aux synaptogyrines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aider à gérer les symptômes neurologiques." } }, { "@type": "Question", "name": "Des interventions chirurgicales sont-elles possibles pour ces troubles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les interventions chirurgicales sont rares et réservées aux cas graves de convulsions." } }, { "@type": "Question", "name": "Les thérapies physiques sont-elles bénéfiques pour les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les thérapies physiques peuvent aider à améliorer la motricité et la coordination." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles des synaptogyrines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles cognitifs sévères et des problèmes de développement." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils des complications possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'humeur peuvent survenir en raison de dysfonctionnements synaptiques." } }, { "@type": "Question", "name": "Les patients peuvent-ils développer des troubles psychiatriques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychiatriques peuvent être associés à des anomalies des synaptogyrines." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de mortalité avec ces troubles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles graves liés aux synaptogyrines peuvent augmenter le risque de mortalité." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des synaptogyrines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques et environnementaux peuvent augmenter le risque de troubles." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles des synaptogyrines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles neurologiques peuvent être un facteur de risque." } }, { "@type": "Question", "name": "Les infections prénatales peuvent-elles affecter les synaptogyrines ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections prénatales peuvent influencer le développement neurologique." } }, { "@type": "Question", "name": "Le stress environnemental est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress environnemental peut contribuer à des troubles neurologiques chez certains individus." } }, { "@type": "Question", "name": "Les facteurs nutritionnels influencent-ils les troubles des synaptogyrines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une nutrition inadéquate peut affecter le développement cérébral et synaptique." } } ] } ] }

Sources (10000 au total)

Consumption of very low-mineral water may threaten cardiovascular health by increasing homocysteine in children.

Homocysteine (Hcy) is a critical factor for cardiovascular injury, and the elevation of Hcy in children will inevitably increase the risk of cardiovascular disease in adulthood. This study explored th... This was a retrospective cohort study that recruited two groups of 10-13-year-old children who had consumed direct drinking water (DDW) in school for 4 years. The control group (NW) (119 boys, 110 gir... Compared with the NW group, the VLW group had significantly higher serum Hcy, Apo-B, Apo-B/A1, and oxLDL, and lower serum 1,25,(OH)... This study suggested that drinking very low-mineral water may increase Hcy level and oxidative stress, worsen lipid profile, and threaten the cardiovascular system in children. Reducing 1,25,(OH)...

Heart Rate Recovery Assessed by Cardiopulmonary Exercise Testing in Patients with Cardiovascular Disease: Relationship with Prognosis.

The use of exercise testing has expanded in recent decades and there is a wealth of information examining the prognostic significance of exercise variables, such as peak oxygen consumption or ventilat... We aim to provide an overview of the literature surrounding HRR and its prognostic significance in patients with cardiovascular disease undertaking an exercise test.... In December 2020, searches of PubMed, Scopus, and ScienceDirect were performed using key search terms and Boolean operators.... Articles were manually screened and selected as per the inclusion criteria.... Nineteen articles met inclusion criteria and were reviewed. Disagreement exists in methodologies used for measuring and assessing HRR. However, HRR provides prognostic mortality information for use in... HRR is a simple, non-invasive measure which independently predicts mortality in patients with heart failure and coronary artery disease; HRR should be routinely incorporated into clinical exercise tes...

Cardiovascular Risk Factors in Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

The interruption of vascular supply to the inner ear is one of several proposed etiologies of sudden sensorineural hearing loss (SSNHL). The increased presence of cardiovascular risk factors may predi... Databases included PubMed/Medline, OVID, EMBASE, Cochrane, and Web of Science.... Inclusion criteria included studies featuring SSNHL patients presenting with 1+ cardiovascular risk factors. Exclusion criteria included case reports and studies without outcome measures. Two investig... Of 532 identified abstracts, 27 studies met inclusion criteria (19 case-control, 4 cohorts, 4 case series). Of these, 24 underwent meta-analysis encompassing a total of 77,566 patients (22,620 SSNHL p... Patients presenting with SSNHL have a significantly higher risk of concomitant diabetes, hypertension, and higher total cholesterol in comparison to matched controls. This may indicate a higher cardio...

Cardiovascular Disease-Related Emergency Department Visits and Hospitalization among Women with Hypertensive Disorders of Pregnancy.

The risk of developing cardiovascular disease is higher for women who had hypertensive disorders of pregnancy than for women without a history of hypertensive disorders of pregnancy. However, it is un... This study included participants from the California Teachers Study (N=58,718) with a history of pregnancy and data from 1995 through 2020. Incidence of cardiovascular disease-related emergency depart... A total of 5% of the women had a history of hypertensive disorders of pregnancy (5.4%, 95% CI=5.2%, 5.6). A total of 31% of women had 1 or more cardiovascular disease-related emergency department visi... History of hypertensive disorders of pregnancy is associated with higher cardiovascular disease-related emergency department visits and hospitalizations. These findings underscore the potential burden...

Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients.

Remnant cholesterol (RC) adversely contributes to cardiovascular disease (CVD) and overall survival in various diseases. However, its role in CVD outcomes and all-cause mortality in patients undergoin... Based on lipid profiles recorded using standard laboratory procedures, fasting RC levels were calculated in 2710 incident patients undergoing PD who were enrolled between January 2006 and December 201... An increased RC level was independently associated with all-cause and CVD mortality in patients undergoing PD, suggesting that RC was important clinically and required further research....

Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.

Inflammation is gaining attention as a target for prevention of atherosclerotic cardiovascular disease (ASCVD). The purpose of this review is to compare the evidence for inflammation with the evidence... Evidence from human genetic studies and randomized controlled trials implicate the inflammatory pathway from the inflammasome through interleukin (IL)-1 to IL-6 as a cause of ASCVD. Higher levels of I... IL-6 mediated inflammation most likely causes ASCVD, in parallel with LDL cholesterol. However, fewer individuals in the general population are exposed to high IL-6 than high LDL cholesterol. For infl...

Two-year changes in body composition and future cardiovascular events: a longitudinal community-based study.

The risk of cardiovascular diseases has rapidly increased among middle-aged and elderly. However, little is known about the relationship of body composition changes with the risk of cardiovascular eve... This study included 1048 participants (456 men [43.51%], aged 50-80 years) without overt cardiovascular disease, who underwent two examinations during 2013-2014 and 2015-2016. All participants were fo... At baseline, the median body mass index (BMI), fat%, and FFM% were 23.9 (22.1-25.9) kg/m... In a middle-aged and elderly community-based Chinese population, fat% gain or FFM% loss was associated with an increased risk of cardiovascular events....